U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.
Shares of Globant S.A. (NYSE:GLOB) fell sharply in today’s pre-market trading after the company reported worse-than-expected first-quarter financial results, issued second-quarter guidance below estimates, and cut its FY25 guidance.
Globant reported quarterly earnings of $1.50 per share which missed the analyst consensus estimate of $1.58 per share. The company reported quarterly sales of $611.09 million which missed the analyst consensus estimate of $621.38 million.
Globant shares dipped 26.2% to $98.00 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Doximity, Inc. (NYSE:DOCS) dipped 22.1% to $45.52 in pre-market trading after the company issued FY26 sales guidance below estimates.
- Travere Therapeutics, Inc. (NASDAQ:
Full story available on Benzinga.com
U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.
Shares of Globant S.A. (NYSE:GLOB) fell sharply in today’s pre-market trading after the company reported worse-than-expected first-quarter financial results, issued second-quarter guidance below estimates, and cut its FY25 guidance.
Globant reported quarterly earnings of $1.50 per share which missed the analyst consensus estimate of $1.58 per share. The company reported quarterly sales of $611.09 million which missed the analyst consensus estimate of $621.38 million.
Globant shares dipped 26.2% to $98.00 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Doximity, Inc. (NYSE:DOCS) dipped 22.1% to $45.52 in pre-market trading after the company issued FY26 sales guidance below estimates.
- Travere Therapeutics, Inc. (NASDAQ:
Full story available on Benzinga.com
U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.
Shares of Globant S.A. (NYSE:GLOB) fell sharply in today’s pre-market trading after the company reported worse-than-expected first-quarter financial results, issued second-quarter guidance below estimates, and cut its FY25 guidance.
Globant reported quarterly earnings of $1.50 per share which missed the analyst consensus estimate of $1.58 per share. The company reported quarterly sales of $611.09 million which missed the analyst consensus estimate of $621.38 million.
Globant shares dipped 26.2% to $98.00 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
Doximity, Inc. (NYSE:DOCS) dipped 22.1% to $45.52 in pre-market trading after the company issued FY26 sales guidance below estimates.
Travere Therapeutics, Inc. (NASDAQ:Full story available on Benzinga.com Read MoreAMAT, ARAI, big losers, BRFS, DOCS, GLOB, KULR, LAC, News, Premarket Movers, TTWO, TVTX, Pre-Market Outlook, Markets, Movers, Trading Ideas, AMAT, US0382221051, TTWO, US8740541094, BRFS, US10552T1079, LAC, GLOB, KULR, TVTX, DOCS, ARAI, News, Pre-Market Outlook, Markets, Movers, Trading Ideas, Benzinga Markets
